Dr. Funari's scientific career spans two decades developing or encompassing
new genomic approaches to unfold new mysteries of human genetic diseases.
Not exact matches
But it has been disappointing in that the kind of genetic variation it detects has turned out to explain surprisingly little of the genetic links to most diseases... One issue of debate among researchers is whether, despite the prospect of diminishing returns, to continue with the genomewide studies, which cost many millions of dollars apiece, or switch to a
new approach like decoding the entire genomes of individual patients.The unexpected impasse also affects companies that offer personal
genomic information and that had assumed they could inform customers of their genetic risk for common diseases, based on researchers» discoveries...
Traditional genetic
approaches together with the
new wealth of
genomic information for both human and model organisms open up strategies by which drugs can be profiled for their ability to selectively kill cells in a molecular context that matches those found in tumors.
Since the completion of the Human Genome Project in 2003, scientists have expanded their knowledge of how living cells work with
new approaches including
genomics, proteomics, and systems biology.
But now «the
approach can be reset using the bacterial and human
genomic data,» says immunologist Steven Schutzer of the University of Medicine and Dentistry of
New Jersey.
The advances in genotyping and functional
genomics open
new approaches to environmental science, including public health issues
The move comes in response to the announcement earlier this week of a
new U.S. company, launched by sequencing - machine manufacturer Perkin - Elmer and J. Craig Venter of The Institute for
Genomic Research, that plans a brute - force
approach to sequencing the human genome within 3 years (ScienceNOW, 12 May).
Exomes and the Clinical Research Conundrum:
New Approaches to Enhancing the Value of
Genomic Data
Identifying how
genomic islands move and their effect on bacterial physiology could lead to
new approaches to bypass bacterial defenses, Hudson said.
It is widely known that
genomics has already begun to influence medicine and that bioinformatics holds the key for developing
new medical
approaches, but how does medical
genomics really work?
«
New approaches in medical
genomics: A step forward in Parkinson's disease.»
To overcome the extreme
genomic complexity, the team used
new long - read sequencing technology that boosted the quality of the genome sequence obtained by more than one hundred fold over standard short - read
approaches.
In a study of 124 patients with advanced breast, lung, and prostate cancers, a
new, high - intensity
genomic sequencing
approach detected circulating tumor DNA at a high rate.
A
new method by researchers from New England Biolabs and New Mexico State University provides plant biologists with a quick and simple approach for separating plant nuclear DNA from organellar DNA for genomic and metagenomic studi
new method by researchers from
New England Biolabs and New Mexico State University provides plant biologists with a quick and simple approach for separating plant nuclear DNA from organellar DNA for genomic and metagenomic studi
New England Biolabs and
New Mexico State University provides plant biologists with a quick and simple approach for separating plant nuclear DNA from organellar DNA for genomic and metagenomic studi
New Mexico State University provides plant biologists with a quick and simple
approach for separating plant nuclear DNA from organellar DNA for
genomic and metagenomic studies.
«We're confident that applying this same
approach to a lot of
new data will help us discover additional
genomic variations and identify specific genes that play a role in schizophrenia and other psychiatric conditions.»
Interestingly,
genomic analyses suggested that ESCC and head and neck squamous cell carcinoma (HNSCC) shared some common pathogenic mechanisms, and ESCC development is associated with alcohol drinking.These findings would provide a brand -
new insight into the understandings of ESCC tumorigenesis, and would help clinicians to develop more effective diagnostic and therapeutic
approaches for ESCC.
-- In silico basic and systems biology: We develop innovative
approaches to reverse engineer biological networks from omics data, model tumor progression at the
genomic, transcriptomic and epigenetic level, automatically annotate
new proteins and functional elements through integration of complex and heterogeneous data, including data obtained from high - throughput sequencing or time - lapse video - microscopy.
Vinetz said the next step will be to begin exploiting the
genomic information «for vaccine and diagnostics development, experimental
approaches to understanding mechanisms of disease pathogenesis and how Leptospira persist in the environment, all critical for developing
new public health interventions aimed at reducing the global impact of this important but neglected zoonotic disease.»
Identification of
new pathological biomarkers for monogenic diseases using a functional
genomic approach.
Currently, we are exploring several environmental samples retrieved from allover the world - ranging from hydrothermal vents in Japan to hot springs in Yellowstone National Park and
New Zealand — for the presence of novel archaeal (and bacterial) lineages using cultivation - independent
approaches, such as metagenomics and single cell
genomics.
Disa will work on the
genomic exploration of «microbial dark matter», focusing on
new archaeal lineages and viruses, using both lab - and bioionformatics - based
approaches.
The study, integration and analysis of these data increasingly allows to unravel the genetic mechanisms and networks underlying complex biological phenotypes paving the way for an era of «
genomic medicine,» in which
new diagnostic and therapeutic
approaches to common multifactorial conditions are emerging.
«Our goal is to use comparative
genomics approaches to fill in gaps in our understanding of how plant reproduction works and to define the aspects of the mechanisms we've discovered so far that are either ancient or
new innovations.»
The Functional
Genomic and Computational Assessment of Threats (Fun GCAT) program challenges research teams to develop
new approaches for screening genetic information for evidence of a potential biological threat.
Information gained from this work will serve to enhance the clinical usefulness of findings from
genomic sequencing (for example, next - generation sequencing or comprehensive
genomic profiling), determine therapeutic
approaches based on
genomic findings, aid in the development of clinical trials and related options, and provide supportive rationale for exploring
new therapies.
These
approaches are important complements to empirical studies, generating
new predictions that we can test with
genomic data or in field or greenhouse experiments.
Ultimately, integrating the vast datasets generated by these different atlases may prove the greatest challenge of all — but, the researchers hope, it will also be the most rewarding, combining structural,
genomic and epigenetic
approaches under the umbrella of a
new kind of cartographic exploration.
MELGEN will explore emergent
new techniques, for example the Sanger Institute (GRL) and ServiceXS will explore
new approaches to
genomic data generation from such samples and from fresh tumour and, critically, with other participant groups develop
new statistical / bioinformatic
approaches to data analysis.
The branch serves as a focal point at the NIH campus for the analysis of a wide variety of large - scale
genomic data generated in the course of laboratory and clinical studies, with branch members actively involved in efforts aimed at developing
new bioinformatic
approaches for the analysis and visualization of these data.
Liaison between clinical and basic sciences can be utilized to achieve this, including maximizing the potential of
genomic data to tailor individualized treatments, collecting natural history information to identify disorder - specific management requirements, developing
new therapeutic
approaches through improved knowledge of molecular pathways and protein network interactions, and testing potential
new drugs via well - conducted clinical trials.
Here, we discuss and illustrate the strengths and weaknesses of
approaches for the annotation and classification of important elements of protein - coding genes, other
genomic elements such as pseudogenes and the non-coding genome, comparative -
genomic approaches for inferring gene function, and
new technologies for aiding genome annotation, as a practical guide for clinicians when considering pathogenic sequence variation.
Our
approach blends
new genomic technologies with established ecological principles.
Jesse Ausubel served on the Task Force, whose report explores
new genomic, acoustic, and optical
approaches, and their synergies, especially in relation to the deep ocean, and some organizational strategies to speed progress.